MedPath

Randomized, open-label, crossover study to evaluaute an effects of genetic polymorphism on pharmacokinetic & pharmacodynamic interactions of clopidogrel and cilostazol in Korean healthy adult volunteers

Not Applicable
Completed
Conditions
Not Applicable
Registration Number
KCT0000443
Lead Sponsor
Inje University Busan Paik Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
27
Inclusion Criteria

Healthy subjects aged between 20 and 45 years old with standard weight.

Exclusion Criteria

Subject who has abnormal laboratory test results

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cmax;AUCt
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath